Erik Berglund

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Erik Berglund, M.D., Ph.D., Associate Professor of Experimental
Transplantation Surgery
Erik Berglund, M.D., Ph.D., is an Associate Professor of Experimental
Transplantation Surgery at Karolinska Institute focused mainly on
transplantation tolerance, novel immunosuppression treatments in allo- and
xenotransplantation, organ machine perfusion, and ischemia-reperfusion
injury.
Erik is trained at Karolinska Institute and Karolinska University Hospital
where he specialized in Transplantation Surgery and Translational Immunology.
Erik earned his Ph.D. degree discovering novel molecular biology aspects of
soft tissue sarcomas and has worked as a faculty member at Columbia
University and the Columbia Center for Translational Immunology (CCTI) in New
York.

Artiklar

Article: BIOCHEMISTRY AND BIOPHYSICS REPORTS. 2022;30:101260
Inward and outward currents of native and cloned K(ATP) channels (Kir6.2/SUR1) share single-channel kinetic properties
Branstrom R; Berglund E; Frobom R; Leibiger IB; Leibiger B; Aspinwall CA; Larsson O; Berggren P-O
Article: TRANSPLANT INTERNATIONAL. 2021;34(11):2006-2018
Organ transplants of the future: planning for innovations including xenotransplantation
Cozzi E; Schneeberger S; Bellini MI; Berglund E; Boehmig G; Fowler K; Hoogduijn M; Jochmans I; Marckmann G; Marson L; Neuberger J; Oberbauer R; Pierson RNII; Reichart B; Scobie L; White C; Naesens M
Article: JOURNAL OF PROTEOME RESEARCH. 2021;20(9):4610-4620
Evaluation of Spin Columns for Human Plasma Depletion to Facilitate MS-Based Proteomics Analysis of Plasma
Cao X; Sandberg A; Araujo JE; Cvetkovski F; Berglund E; Eriksson LE; Pernemalm M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2021;557:14-19
Direct interaction of the ATP-sensitive K⁺ channel by the tyrosine kinase inhibitors imatinib, sunitinib and nilotinib
Frobom R; Berglund E; Aspinwall CA; Lui W-O; Nilsson I-L; Larsson C; Branstrom R
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:599526
Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity
Binder C; Sellberg F; Cvetkovski F; Berg S; Berglund E; Berglund D
Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2020;69(11):2393-2401
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors
Frobom R; Berglund E; Berglund D; Nilsson I-L; Ahlen J; von Sivers K; Linder-Stragliotto C; Suenaert P; Karlsson-Parra A; Branstrom R
Article: TRANSPLANTATION. 2020;104(2):270-279
Impact of CMV Reactivation, Treatment Approaches, and Immune Reconstitution in a Nonmyeloablative Tolerance Induction Protocol in Cynomolgus Macaques.
Alonso-Guallart P; Duran-Struuck R; Zitsman JS; Sameroff S; Pereira M; Stern J; Berglund E; Llore N; Pierre G; Lopes E; Kofman SB; Danton M; Sondermeijer HP; Woodland D; Kato Y; Ekanayake-Alper DK; Iuga AC; Wuu C-S; Wu A; Lipkin WI; Tokarz R; Sykes M; Griesemer A
Article: FRONTIERS IN ONCOLOGY. 2020;10:598394
Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent
Sellberg F; Frobom R; Binder C; Berglund E; Berglund D
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:592553
Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro
Binder C; Sellberg F; Cvetkovski F; Berglund E; Berglund D
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2020;91(1):e12839
Pharmacokinetic and pharmacodynamic study of a clinically effective anti-CD2 monoclonal antibody
Sellberg F; Berglund D; Binder C; Hope J; Fontenot J; Griesemer A; Sykes M; Sachs DH; Berglund E
Article: TRANSPLANT INTERNATIONAL. 2020;33(1):98-107
Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques - an experimental study
Berglund E; Alonso-Guallart P; Danton M; Sellberg F; Binder C; Frobom R; Berglund D; Llore N; Sakai H; Iuga A; Ekanayake-Alper D; Reimann KA; Sachs DH; Sykes M; Griesemer A
Article: VIRCHOWS ARCHIV. 2019;475(6):781-788
Cause of death and significant disease found at autopsy
Friberg N; Ljungberg O; Berglund E; Berglund D; Ljungberg R; Alafuzoff I; Englund E
Article: TRANSPLANTATION. 2019;103(10):2173-2182
Clinical Significance of Alloantibodies in Hand Transplantation: A Multicenter Study
Berglund E; Andersen Ljungdahl M; Bogdanovic D; Berglund D; Wadstrom J; Kowalski J; Brandacher G; Kaminska D; Kaufman CL; Talbot SG; Azari K; Landin L; Hoehnke C; Dwyer KM; Cavadas PC; Thione A; Clarke B; Kay S; Wilks D; Iyer S; Iglesias M; Ozkan O; Ozkan O; Krapf J; Weissenbacher A; Petruzzo P; Schneeberger S
Article: ANTICANCER RESEARCH. 2019;39(7):3433-3442
Biochemical Inhibition of DOG1/TMEM16A Achieves Antitumoral Effects in Human Gastrointestinal Stromal Tumor Cells In Vitro
Frobom R; Sellberg F; Xu C; Zhao A; Larsson C; Lui W-O; Nilsson I-L; Berglund E; Branstrom R
Article: TRANSPLANTATION DIRECT. 2019;5(3):e432
Long-term Outcome of Endoscopic and Percutaneous Transhepatic Approaches for Biliary Complications in Liver Transplant Recipients
Roenning J; Berglund E; Arnelo U; Ericzon B-G; Nowak G
Article: JCI INSIGHT. 2018;3(22):124086
Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.
Savage TM; Shonts BA; Obradovic A; Dewolf S; Lau S; Zuber J; Simpson MT; Berglund E; Fu J; Yang S; Ho S-H; Tang Q; Turka LA; Shen Y; Sykes M
Article: CELL TRANSPLANTATION. 2018;27(11):1692-1704
Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade
Watanabe M; Kumagai-Braesch M; Yao M; Thunberg S; Berglund D; Sellberg F; Jorns C; Enoksson SL; Henriksson J; Lundgren T; Uhlin M; Berglund E; Ericzon B-G
Article: EXPERIMENTAL CELL RESEARCH. 2018;371(1):287-296
miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors
Huang W-K; Akcakaya P; Gangaev A; Lee L; Zeljic K; Hajeri P; Berglund E; Ghaderi M; Ahlen J; Branstrom R; Larsson C; Lui W-O
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2018;53(7):876-882
Liver transplantation for acute liver failure - a 30-year single center experience
Sars C; Tranang M; Ericzon B-G; Berglund E
Article: TRANSFUSION AND APHERESIS SCIENCE. 2016;55(3):333-337
Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet units
Sellberg F; Berglund E; Ronaghi M; Strandberg G; Lof H; Sommar P; Lubenow N; Knutson F; Berglund D
Article: EXPERIMENTAL CELL RESEARCH. 2015;336(1):158-170
Secretome protein signature of human gastrointestinal stromal tumor cells
Berglund E; Dare E; Branca RMM; Akcakaya P; Frobom R; Berggren P-O; Lui W-O; Larsson C; Zedenius J; Orre L; Lehtio J; Kim J; Branstrom R
Article: BRITISH JOURNAL OF CANCER. 2014;111(11):2091-2102
microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome
Akcakaya P; Caramuta S; Ahlen J; Ghaderi M; Berglund E; Ostman A; Branstrom R; Larsson C; Lui W-O
Article: EXPERIMENTAL CELL RESEARCH. 2014;326(2):315-325
Functional role of the Ca²⁺-activated Cl^- channel DOG1/TMEM16A in gastrointestinal stromal tumor cells
Berglund E; Akcakaya P; Berglund D; Karlsson F; Vukojevic V; Lee L; Bogdanovic D; Lui W-O; Larsson C; Zedenius J; Frobom R; Branstrom R
Article: ANTI-CANCER DRUGS. 2014;25(4):415-422
Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells
Berglund E; Ubhayasekera SJKA; Karlsson F; Akcakaya P; Aluthgedara W; Ahlen J; Frobom R; Nilsson I-L; Lui W-O; Larsson C; Zedenius J; Bergquist J; Branstrom R
Article: EXPERIMENTAL CELL RESEARCH. 2013;319(8):1229-1238
Evidence for Ca²⁺-regulated ATP release in gastrointestinal stromal tumors
Berglund E; Berglund D; Akcakaya P; Ghaderi M; Dare E; Berggren P-O; Kohler M; Aspinwall CA; Lui W-O; Zedenius J; Larsson C; Branstrom R
Article: TRANSPLANT IMMUNOLOGY. 2011;24(4):246-250
Screening of mortality in transplant patients using an assay for immune function
Berglund D; Bengtsson M; Biglarnia A; Berglund E; Yamamoto S; von Zur-Muthlen B; Lorant T; Tufveson G
Article: PLOS ONE. 2011;6(4):e18213
Evidence for Presence and Functional Effects of Kv1.1 Channels in β-Cells: General Survey and Results from mceph/mceph Mice
Ma Z; Lavebratt C; Almgren M; Portwood N; Forsberg LE; Branstrom R; Berglund E; Falkmer S; Sundler F; Wierup N; Bjorklund A
Article: JOURNAL OF ENDOCRINOLOGY. 2011;208(1):31-39
Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma
Lu M; Berglund E; Larsson C; Hoog A; Farnebo L-O; Branstrom R
Article: JOURNAL OF MEDICAL CASE REPORTS. 2010;4:315
Electrical short-circuit in β-cells from a patient with non-insulinoma pancreatogenous hypoglycemic syndrome (NIPHS): a case report.
Bränström R; Berglund E; Curman P; Forsberg L; Höög A; Grimelius L; Berggren P-O; Mattsson P; Hellman P; Juntti-Berggren L
Article: JOURNAL OF MOLECULAR ENDOCRINOLOGY. 2010;44(5):285-294
Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid
Lu M; Branstrom R; Berglund E; Hoog A; Bjorklund P; Westin G; Larsson C; Farnebo L-O; Forsberg L
Visa fler

Alla övriga publikationer

Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(5):2253
Strategies for Liver Transplantation Tolerance
Cvetkovski F; Hexham JM; Berglund E
Review: FRONTIERS IN IMMUNOLOGY. 2020;11:1090
CD2 Immunobiology
Binder C; Cvetkovski F; Sellberg F; Berg S; Visbal HP; Sachs DH; Berglund E; Berglund D
Meeting abstract: CANCER RESEARCH. 2019;79(13):1260
Inhibition of DOG1, or TMEM16A, results in antitumoral effects in gastrointestinal stromal tumors (GIST) in vitro
Frobom R; Berglund E; Branstrom R
Letter: CYTOTHERAPY. 2017;19(2):329-332
Assessing the purity of regulatory T cells: A humble reminder
Berglund E; Sellberg F; Berglund D
Thesis / dissertation: 2014
Novel aspects of the molecular biology of gastrointestinal stromal tumors
Berglund, Erik
Meeting abstract: CANCER RESEARCH. 2013;73(8):5317
Evidence for intracellular calcium-regulated secretion in gastrointestinal stromal tumor.
Berglund E; Berglund D; Akcakaya P; Ghaderi M; Dare E; Berggren P-O; Aspinwall CA; Lui W-O; Zedenius J; Larsson C; Branstrom R

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2023-2026
Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2022-2025

Examina och utbildning

Docent, Experimentell transplantationskirurgi, Karolinska Institutet, 2020
Medicine Doktorsexamen, Institutionen för molekylär medicin och kirurgi, Karolinska Institutet, 2014
Läkarexamen, Karolinska Institutet, 2012

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI